Physician profile
Jay Jaiswal
NPI 1417527276
$2,067.69
in general payments reported to CMS, 2019-2025
22 companies · $1,618 in 2025
The $1,618 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $42.33 · 2024: $408 · 2025: $1,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,872 · Education: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,871.68 |
| Education | $196.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $493.26 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.03 | 2024-2025 | Lifevest |
| Pfizer INC. | $206.08 | 2024-2025 | |
| Medtronic, INC. | $179.68 | 2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $144.01 | 2024 | Ensite |
| Novo Nordisk INC | $117.45 | 2025 | Ozempic |
| Abiomed | $112.77 | 2025 | |
| Merck Sharp & Dohme LLC | $101.00 | 2024-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $60.84 | 2025 | Farxiga |
| Amgen INC. | $50.55 | 2024-2025 | Repatha, Repatha |
| Stryker Corporation | $49.77 | 2025 | Clottriever Bold Catheter |
| Edwards Lifesciences Corporation | $48.02 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Alnylam Pharmaceuticals INC. | $37.67 | 2025 | Onpattro |
| Bridgebio Pharma, INC. | $35.07 | 2025 | Attruby |
| Boston Scientific Corporation | $30.04 | 2025 | Bodyguardian |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $27.43 | 2024-2025 | |
| Heartflow, INC. | $26.94 | 2025 | |
| Lilly USA, LLC | $23.12 | 2023 | Taltz |
| Irhythm Technologies, INC. | $21.30 | 2024 | Zio Xt Patch, Zio Monitor |
| Exact Sciences Corporation | $19.27 | 2024 | Cologuard Collection Kit |
| Fresenius Kabi USA, LLC | $19.21 | 2023 | Idacio |
| Bayer Healthcare Pharmaceuticals INC. | $14.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Jaiswal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.